Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases
Annals of Clinical and Translational Neurology · 2025-07 · 12 (7) · 1465-1479
DOI: 10.1002/acn3.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 25.05.2025. Verfasst von Alba Segarra-Casas und 24 weiteren Autor:innen. Beteiligte Einrichtung: Join Research Unit on Genomic Medicine Universitat Autonòma de Barcelona-IR SANT PAU, Barcelona, Spain. Hauptthemen laut MEDLINE: Muscular Diseases, Muscle, Skeletal, Muscular Dystrophies, RNA-Seq. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Ciencia, Innovación de Universidades, Instituto de Salud Carlos III, Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
Objective
Approximately half of patients with hereditary myopathies remain without a definitive genetic diagnosis after DNA next‐generation sequencing (NGS). Here, we implemented transcriptome analysis of muscle biopsies as a complementary diagnostic tool for patients with muscle disease but no definitive genetic diagnosis after exome sequencing.
Methods
In total, 70 undiagnosed cases with suspected genetic muscular dystrophies or congenital myopathies were included in the study. Muscle RNAseq comprised the analysis of aberrant splicing, aberrant expression, and monoallelic expression. In addition, existing NGS data or variant calling from RNAseq were reanalyzed, and genome sequencing was performed in selected cases. Four aberrant splicing open‐source tools were compared and assessed.
Results
RNAseq established a diagnosis in 10/70 patients (14.3%) by identifying aberrant transcripts produced by single nucleotide variants (7/10) or copy number variants (3/10). Reanalysis of NGS data allowed the diagnosis in 9/70 individuals (12.9%). Based on this cohort, FRASER was the tool that reported more splicing outlier events per sample while showing the highest accuracy (81.26%).
Conclusions
We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Join Research Unit on Genomic Medicine Universitat Autonòma de Barcelona-IR SANT PAU, Barcelona, Spain.
- Genetics Department, Institut de Recerca Sant Pau (IR SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Genetics and Microbiology Department, Universitat Autonòma de Barcelona, Bellaterra, Spain.
- Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Neuromuscular Disorders Unit, Neurology Department, imas12 Research Institute, Hospital Universitario, Madrid, Spain.
- Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
ORCID-Profile: Alba Segarra-Casas, Daniel Natera-de Benito, Berta Estévez-Arias, Laura Llansó, Cecília Jimenez-Mallebrera
Förderung
- Ministerio de Ciencia, Innovación de Universidades
- Instituto de Salud Carlos III
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- European Union
- European Commission
Zitieren
APA
Segarra-Casas, A., Domínguez-González, C., Natera-de Benito, D., Kapetanovic, S., Hernández-Laín, A., Estévez-Arias, B., Llansó, L., Ortez, C., Jou, C., Martí-Carrera, I., López-Márquez, A., Rodríguez, M. J., González-Mera, L., Nedkova, V., Fernández-Torrón, R., Rodríguez-Santiago, B., Jimenez-Mallebrera, C., Juntas-Morales, R., López-de Munain, A., …, & González-Quereda, L. (2025). Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases. Annals of Clinical and Translational Neurology, 12(7), 1465-1479. https://doi.org/10.1002/acn3.70078
Vancouver
Segarra-Casas A, Domínguez-González C, Natera-de Benito D, Kapetanovic S, Hernández-Laín A, Estévez-Arias B, et al. Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases. Annals of Clinical and Translational Neurology. 2025;12(7):1465-1479. doi:10.1002/acn3.70078
BibTeX
@article{SegarraCasas2025,
author = {Segarra-Casas, Alba and Domínguez-González, Cristina and Natera-de Benito, Daniel and Kapetanovic, Solange and Hernández-Laín, Aurelio and Estévez-Arias, Berta and Llansó, Laura and Ortez, Carlos and Jou, Cristina and Martí-Carrera, Itxaso and López-Márquez, Arístides and Rodríguez, Maria José and González-Mera, Laura and Nedkova, Velina and Fernández-Torrón, Roberto and Rodríguez-Santiago, Benjamín and Jimenez-Mallebrera, Cecília and Juntas-Morales, Raul and López-de Munain, Adolfo and Surrallés, Jordi and Nascimento, Andrés and Gallardo, Eduard and Olivé, Montse and Gallano, Pia and González-Quereda, Lidia},
title = {Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {7},
pages = {1465--1479},
doi = {10.1002/acn3.70078}
}
EUVIMED